Daniel A. Giannini, Director at NxStage Medical, Inc. (NXTM), sold 6,593 shares at $20.30 ($134K) on 2015-11-09, disclosed to the SEC on 2015-11-10.
Open-market sale of $134k NXTM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.